Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 19 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 9556200

    Tricyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  2. US 9556130

    4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139

    Takeda Pharmaceutical Company Limited · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  3. US 9550756

    Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

    Takeda Pharmaceutical Company Limited · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  4. US 9533966

    Cyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  5. US 9527841

    Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted
  6. US 9527807

    Sulfonamide derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted
  7. US 9517210

    Method for producing microcapsule powder

    Takeda Pharmaceutical Company Limited · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  8. US 9518042

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  9. US 9512118

    Crystal of fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  10. US 9505772

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  11. US 9499516

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  12. US 9499568

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  13. US 9493432

    Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders

    Takeda Pharmaceutical Company Limited · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  14. US 9493484

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  15. US 9487526

    Quinoxaline derivatives as GPR6 modulators

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  16. US 9487485

    Method for producing sulfonyl chloride compound

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  17. US 9486411

    Solid preparation

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  18. US 9486446

    Orally disintegrating solid preparation

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  19. US 9487511

    Cyclopropanamine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  20. US 9487509

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  21. US 9475795

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Takeda Pharmaceutical Company Limited · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  22. US 9475816

    Substituted-1,4-dihydropyrazolo[4,3-b]indoles

    Takeda Pharmaceutical Company Limited · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  23. US 9475822

    Substituted 2- amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  24. US 9469637

    Nitrogenated heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted